Industry: Consumer Goods
Published Date: 2024-04-26
Pages: 112 Pages
Report ld: 3098661
Request Sample
Customized Report
Veterinary pet supplements and nutraceuticals are widely used by dog, cat and horse owners across the United States, generating millions of dollars in revenue for manufacturers. Despite the widespread use of these veterinary products, oversight and regulation remain limited as compared to human dietary supplement regulations. This review describes the current regulation, quality control, safety and efficacy of pet supplements and nutraceuticals targeted towards the dog, cat and horse.
Market Analysis and Insights: Global Dog Pharmaceuticals and Supplements Market
The global Dog Pharmaceuticals and Supplements market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Dog Pharmaceuticals and Supplements is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Dog Pharmaceuticals and Supplements is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Dog Pharmaceuticals and Supplements is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Dog Pharmaceuticals and Supplements include Virbac, Zoetis, Vetoquinol, Nestle Purina, NOW Foods, Nutramax Laboratories, Bayer, Foodscience corporation and Manna Pro Products, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Dog Pharmaceuticals and Supplements is widely used in various fields, such as Puppy and Adult Dogs, etc. Puppy provides greatest supports to the Dog Pharmaceuticals and Supplements industry development. In 2023, global % revenue of Dog Pharmaceuticals and Supplements went into Puppy filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Dog Pharmaceuticals and Supplements market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Dog Pharmaceuticals and Supplements, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Dog Pharmaceuticals and Supplements, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dog Pharmaceuticals and Supplements revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Dog Pharmaceuticals and Supplements market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Dog Pharmaceuticals and Supplements revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Virbac, Zoetis, Vetoquinol, Nestle Purina, NOW Foods, Nutramax Laboratories, Bayer, Foodscience corporation and Manna Pro Products, etc.
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dog Pharmaceuticals and Supplements Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Pharmaceuticals
1.2.3 Supplements
1.3 Market by Application
1.3.1 Global Dog Pharmaceuticals and Supplements Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Puppy
1.3.3 Adult Dogs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dog Pharmaceuticals and Supplements Market Perspective (2019-2030)
2.2 Global Dog Pharmaceuticals and Supplements Growth Trends by Region
2.2.1 Dog Pharmaceuticals and Supplements Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Dog Pharmaceuticals and Supplements Historic Market Size by Region (2019-2024)
2.2.3 Dog Pharmaceuticals and Supplements Forecasted Market Size by Region (2025-2030)
2.3 Dog Pharmaceuticals and Supplements Market Dynamics
2.3.1 Dog Pharmaceuticals and Supplements Industry Trends
2.3.2 Dog Pharmaceuticals and Supplements Market Drivers
2.3.3 Dog Pharmaceuticals and Supplements Market Challenges
2.3.4 Dog Pharmaceuticals and Supplements Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Dog Pharmaceuticals and Supplements by Players
3.1.1 Global Dog Pharmaceuticals and Supplements Revenue by Players (2019-2024)
3.1.2 Global Dog Pharmaceuticals and Supplements Revenue Market Share by Players (2019-2024)
3.2 Global Dog Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Dog Pharmaceuticals and Supplements, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Dog Pharmaceuticals and Supplements Market Concentration Ratio
3.4.1 Global Dog Pharmaceuticals and Supplements Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dog Pharmaceuticals and Supplements Revenue in 2023
3.5 Global Key Players of Dog Pharmaceuticals and Supplements Head office and Area Served
3.6 Global Key Players of Dog Pharmaceuticals and Supplements, Product and Application
3.7 Global Key Players of Dog Pharmaceuticals and Supplements, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Dog Pharmaceuticals and Supplements Breakdown Data by Type
4.1 Global Dog Pharmaceuticals and Supplements Historic Market Size by Type (2019-2024)
4.2 Global Dog Pharmaceuticals and Supplements Forecasted Market Size by Type (2025-2030)
5 Dog Pharmaceuticals and Supplements Breakdown Data by Application
5.1 Global Dog Pharmaceuticals and Supplements Historic Market Size by Application (2019-2024)
5.2 Global Dog Pharmaceuticals and Supplements Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Dog Pharmaceuticals and Supplements Market Size (2019-2030)
6.2 North America Dog Pharmaceuticals and Supplements Market Size by Type
6.2.1 North America Dog Pharmaceuticals and Supplements Market Size by Type (2019-2024)
6.2.2 North America Dog Pharmaceuticals and Supplements Market Size by Type (2025-2030)
6.2.3 North America Dog Pharmaceuticals and Supplements Market Share by Type (2019-2030)
6.3 North America Dog Pharmaceuticals and Supplements Market Size by Application
6.3.1 North America Dog Pharmaceuticals and Supplements Market Size by Application (2019-2024)
6.3.2 North America Dog Pharmaceuticals and Supplements Market Size by Application (2025-2030)
6.3.3 North America Dog Pharmaceuticals and Supplements Market Share by Application (2019-2030)
6.4 North America Dog Pharmaceuticals and Supplements Market Size by Country
6.4.1 North America Dog Pharmaceuticals and Supplements Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Dog Pharmaceuticals and Supplements Market Size by Country (2019-2024)
6.4.3 North America Dog Pharmaceuticals and Supplements Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Dog Pharmaceuticals and Supplements Market Size (2019-2030)
7.2 Europe Dog Pharmaceuticals and Supplements Market Size by Type
7.2.1 Europe Dog Pharmaceuticals and Supplements Market Size by Type (2019-2024)
7.2.2 Europe Dog Pharmaceuticals and Supplements Market Size by Type (2025-2030)
7.2.3 Europe Dog Pharmaceuticals and Supplements Market Share by Type (2019-2030)
7.3 Europe Dog Pharmaceuticals and Supplements Market Size by Application
7.3.1 Europe Dog Pharmaceuticals and Supplements Market Size by Application (2019-2024)
7.3.2 Europe Dog Pharmaceuticals and Supplements Market Size by Application (2025-2030)
7.3.3 Europe Dog Pharmaceuticals and Supplements Market Share by Application (2019-2030)
7.4 Europe Dog Pharmaceuticals and Supplements Market Size by Country
7.4.1 Europe Dog Pharmaceuticals and Supplements Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Dog Pharmaceuticals and Supplements Market Size by Country (2019-2024)
7.4.3 Europe Dog Pharmaceuticals and Supplements Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Dog Pharmaceuticals and Supplements Market Size (2019-2030)
8.2 China Dog Pharmaceuticals and Supplements Market Size by Type
8.2.1 China Dog Pharmaceuticals and Supplements Market Size by Type (2019-2024)
8.2.2 China Dog Pharmaceuticals and Supplements Market Size by Type (2025-2030)
8.2.3 China Dog Pharmaceuticals and Supplements Market Share by Type (2019-2030)
8.3 China Dog Pharmaceuticals and Supplements Market Size by Application
8.3.1 China Dog Pharmaceuticals and Supplements Market Size by Application (2019-2024)
8.3.2 China Dog Pharmaceuticals and Supplements Market Size by Application (2025-2030)
8.3.3 China Dog Pharmaceuticals and Supplements Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Dog Pharmaceuticals and Supplements Market Size (2019-2030)
9.2 Asia Dog Pharmaceuticals and Supplements Market Size by Type
9.2.1 Asia Dog Pharmaceuticals and Supplements Market Size by Type (2019-2024)
9.2.2 Asia Dog Pharmaceuticals and Supplements Market Size by Type (2025-2030)
9.2.3 Asia Dog Pharmaceuticals and Supplements Market Share by Type (2019-2030)
9.3 Asia Dog Pharmaceuticals and Supplements Market Size by Application
9.3.1 Asia Dog Pharmaceuticals and Supplements Market Size by Application (2019-2024)
9.3.2 Asia Dog Pharmaceuticals and Supplements Market Size by Application (2025-2030)
9.3.3 Asia Dog Pharmaceuticals and Supplements Market Share by Application (2019-2030)
9.4 Asia Dog Pharmaceuticals and Supplements Market Size by Region
9.4.1 Asia Dog Pharmaceuticals and Supplements Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Dog Pharmaceuticals and Supplements Market Size by Region (2019-2024)
9.4.3 Asia Dog Pharmaceuticals and Supplements Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Dog Pharmaceuticals and Supplements Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Dog Pharmaceuticals and Supplements Market Size by Type
10.2.1 Middle East, Africa, and Latin America Dog Pharmaceuticals and Supplements Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Dog Pharmaceuticals and Supplements Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Dog Pharmaceuticals and Supplements Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Dog Pharmaceuticals and Supplements Market Size by Application
10.3.1 Middle East, Africa, and Latin America Dog Pharmaceuticals and Supplements Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Dog Pharmaceuticals and Supplements Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Dog Pharmaceuticals and Supplements Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Dog Pharmaceuticals and Supplements Market Size by Country
10.4.1 Middle East, Africa, and Latin America Dog Pharmaceuticals and Supplements Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Dog Pharmaceuticals and Supplements Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Dog Pharmaceuticals and Supplements Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Virbac
11.1.1 Virbac Company Details
11.1.2 Virbac Business Overview
11.1.3 Virbac Dog Pharmaceuticals and Supplements Introduction
11.1.4 Virbac Revenue in Dog Pharmaceuticals and Supplements Business (2019-2024)
11.1.5 Virbac Recent Developments
11.2 Zoetis
11.2.1 Zoetis Company Details
11.2.2 Zoetis Business Overview
11.2.3 Zoetis Dog Pharmaceuticals and Supplements Introduction
11.2.4 Zoetis Revenue in Dog Pharmaceuticals and Supplements Business (2019-2024)
11.2.5 Zoetis Recent Developments
11.3 Vetoquinol
11.3.1 Vetoquinol Company Details
11.3.2 Vetoquinol Business Overview
11.3.3 Vetoquinol Dog Pharmaceuticals and Supplements Introduction
11.3.4 Vetoquinol Revenue in Dog Pharmaceuticals and Supplements Business (2019-2024)
11.3.5 Vetoquinol Recent Developments
11.4 Nestle Purina
11.4.1 Nestle Purina Company Details
11.4.2 Nestle Purina Business Overview
11.4.3 Nestle Purina Dog Pharmaceuticals and Supplements Introduction
11.4.4 Nestle Purina Revenue in Dog Pharmaceuticals and Supplements Business (2019-2024)
11.4.5 Nestle Purina Recent Developments
11.5 NOW Foods
11.5.1 NOW Foods Company Details
11.5.2 NOW Foods Business Overview
11.5.3 NOW Foods Dog Pharmaceuticals and Supplements Introduction
11.5.4 NOW Foods Revenue in Dog Pharmaceuticals and Supplements Business (2019-2024)
11.5.5 NOW Foods Recent Developments
11.6 Nutramax Laboratories
11.6.1 Nutramax Laboratories Company Details
11.6.2 Nutramax Laboratories Business Overview
11.6.3 Nutramax Laboratories Dog Pharmaceuticals and Supplements Introduction
11.6.4 Nutramax Laboratories Revenue in Dog Pharmaceuticals and Supplements Business (2019-2024)
11.6.5 Nutramax Laboratories Recent Developments
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Dog Pharmaceuticals and Supplements Introduction
11.7.4 Bayer Revenue in Dog Pharmaceuticals and Supplements Business (2019-2024)
11.7.5 Bayer Recent Developments
11.8 Foodscience corporation
11.8.1 Foodscience corporation Company Details
11.8.2 Foodscience corporation Business Overview
11.8.3 Foodscience corporation Dog Pharmaceuticals and Supplements Introduction
11.8.4 Foodscience corporation Revenue in Dog Pharmaceuticals and Supplements Business (2019-2024)
11.8.5 Foodscience corporation Recent Developments
11.9 Manna Pro Products
11.9.1 Manna Pro Products Company Details
11.9.2 Manna Pro Products Business Overview
11.9.3 Manna Pro Products Dog Pharmaceuticals and Supplements Introduction
11.9.4 Manna Pro Products Revenue in Dog Pharmaceuticals and Supplements Business (2019-2024)
11.9.5 Manna Pro Products Recent Developments
11.10 Ark Naturals
11.10.1 Ark Naturals Company Details
11.10.2 Ark Naturals Business Overview
11.10.3 Ark Naturals Dog Pharmaceuticals and Supplements Introduction
11.10.4 Ark Naturals Revenue in Dog Pharmaceuticals and Supplements Business (2019-2024)
11.10.5 Ark Naturals Recent Developments
11.11 Blackmores
11.11.1 Blackmores Company Details
11.11.2 Blackmores Business Overview
11.11.3 Blackmores Dog Pharmaceuticals and Supplements Introduction
11.11.4 Blackmores Revenue in Dog Pharmaceuticals and Supplements Business (2019-2024)
11.11.5 Blackmores Recent Developments
11.12 Zesty Paws
11.12.1 Zesty Paws Company Details
11.12.2 Zesty Paws Business Overview
11.12.3 Zesty Paws Dog Pharmaceuticals and Supplements Introduction
11.12.4 Zesty Paws Revenue in Dog Pharmaceuticals and Supplements Business (2019-2024)
11.12.5 Zesty Paws Recent Developments
11.13 Nuvetlabs
11.13.1 Nuvetlabs Company Details
11.13.2 Nuvetlabs Business Overview
11.13.3 Nuvetlabs Dog Pharmaceuticals and Supplements Introduction
11.13.4 Nuvetlabs Revenue in Dog Pharmaceuticals and Supplements Business (2019-2024)
11.13.5 Nuvetlabs Recent Developments
11.14 Mavlab
11.14.1 Mavlab Company Details
11.14.2 Mavlab Business Overview
11.14.3 Mavlab Dog Pharmaceuticals and Supplements Introduction
11.14.4 Mavlab Revenue in Dog Pharmaceuticals and Supplements Business (2019-2024)
11.14.5 Mavlab Recent Developments
11.15 Vetafarm
11.15.1 Vetafarm Company Details
11.15.2 Vetafarm Business Overview
11.15.3 Vetafarm Dog Pharmaceuticals and Supplements Introduction
11.15.4 Vetafarm Revenue in Dog Pharmaceuticals and Supplements Business (2019-2024)
11.15.5 Vetafarm Recent Developments
11.16 Nupro Supplements
11.16.1 Nupro Supplements Company Details
11.16.2 Nupro Supplements Business Overview
11.16.3 Nupro Supplements Dog Pharmaceuticals and Supplements Introduction
11.16.4 Nupro Supplements Revenue in Dog Pharmaceuticals and Supplements Business (2019-2024)
11.16.5 Nupro Supplements Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Dog Pharmaceuticals and Supplements was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-11
Pages: 122
USD 3950.00
(Single User License)
The global Dog Pharmaceuticals and Supplements market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-11
Pages: 129
USD 2900.00
(Single User License)
The global Dog Pharmaceuticals and Supplements market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-03
Pages: 158
USD 4900.00
(Single User License)
The global Dog Pharmaceuticals and Supplements market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 104
USD 4250.00
(Single User License)
The global market for Dog Pharmaceuticals and Supplements was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-02
Pages: 123
USD 3950.00
(Single User License)
The global market for Dog Pharmaceuticals and Supplements was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-02
Pages: 97
USD 2900.00
(Single User License)
The global market for Dog Pharmaceuticals and Supplements was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 122
The global Dog Pharmaceuticals and Supplements market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 129
The global Dog Pharmaceuticals and Supplements market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-03
Pages: 158
The global Dog Pharmaceuticals and Supplements market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 104
The global market for Dog Pharmaceuticals and Supplements was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-02
Pages: 123
The global market for Dog Pharmaceuticals and Supplements was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-02
Pages: 97
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now